Is curcumin bioavailability a problem in humans: lessons from clinical trials
- 期刊名称Expert Opinion on Drug Metabolism & Toxicology
- 作者Kunnumakkara, Ajaikumar B.; Harsha, Choudhary; Banik, Kishore; Sailo, Bethsebie L.; Bordoloi, Devivasha; Rajesh, Vikkurthi; Gupta, Subash C; Aggarwal, Bharat B.
- 印刷ISSN1742-5255
- 电子ISSN1744-7607
- 文件大小2141.86KB
- 发表时间2019-07-30
- DOI10.1080/17425255.2019.1650914
Nicotinic acid: clinical considerationsKei, Anastazia; Elisaf, Moses S · Expert Opinion on Drug Safety · 2012
Drug safety evaluation of rosuvastatinToth, Peter P; Dayspring, Thomas D · Expert Opinion on Drug Safety · 2011
Gastrointestinal side effects of drugsMakins, Richard; Ballinger, Anne · Expert Opinion on Drug Safety · 2003
Capecitabine and hand–foot syndromeSaif, Muhammad Wasif · Expert Opinion on Drug Safety · 2011
Immune hemolytic anemia caused by drugsGarratty, George · Expert Opinion on Drug Safety · 2012
Thiazolidinedione safetyKung, Jacqueline; Henry, Robert R · Expert Opinion on Drug Safety · 2012
The safety of thiazolidinedionesTolman, Keith G · Expert Opinion on Drug Safety · 2011
Drug-induced immune hemolytic anemiaSalama, Abdulgabar · Expert Opinion on Drug Safety · 2009